Newsstand Menu

Home / Newsstand / CSHL Stories and Media

CSHL Stories and Media archive for Tag: Adrian Krainer

Filter by tag

President’s essay: Bringing bold visions to life

5/26/2023

CSHL President & CEO Bruce Stillman sees the Laboratory as a global hub for scientific expertise and a powerful launchpad for early-career scientists. Read the story »

Image of mouse pancreas cells with SRSF1 protein

This killer protein causes pancreatic cancer

4/26/2023

CSHL researchers have found that high levels of a protein called SRSF1 can cause pancreatitis and jumpstart tumor development. Read the story »

Krainer named Society for RNA Therapeutics board member

4/18/2023

He helped pioneer the field. It changed medicine. Now, he joins a group of renowned scientists and physicians aiming to take it to the next level. Read the story »

From tragedy, a potential pediatric cancer treatment

4/12/2023

CSHL Professor Adrian Krainer, the man behind the “miracle drug” known as Spinraza®, has found a way to fight a deadly pediatric brain cancer in mice. Read the story »

A new treatment approach for cystic fibrosis

7/14/2022

Molecules called antisense oligonucleotides may help lung cells make a protein missing in people with cystic fibrosis. Read the story »

Image of dropper adding liquid to glass laboratory test tube

The promising drug duo that may improve SMA treatment

7/11/2022

Pairing Spinraza® with a second FDA-approved drug may be a new way to improve the drug’s therapeutic effects in spinal muscular atrophy patients. Read the story »

Krainer awarded Watanabe Prize in Translational Research

6/16/2022

Indiana University School of Medicine honored Krainer for his pioneering work on RNA splicing, which led to the first FDA-approved SMA therapeutic. Read the story »

image of a mouse liver tissue with cancer tumor

Cutting off liver cancer’s nutrient supply chain

2/3/2022

CSHL researchers developed a way to interfere with the energy pathway that allows liver cancer to grow and spread. Read the story »

Editing RNA to fix protein problems in cystic fibrosis

1/27/2022

CSHL researchers found a new way to address a previously untreatable class of mutations in the cystic fibrosis gene. Read the story »

illustration of a single strand ribonucleic acid

The rise of RNA therapeutics

10/14/2021

RNA has been making waves as a new approach to prevent or treat diseases, including COVID-19 and spinal muscular atrophy. Read the story »

Krainer wins Pew grant to study fetal alcohol syndrome

9/15/2021

CSHL Professor Adrian Krainer will study RNA splicing errors that occur in people with the disease and look for treatment targets. Read the story »

photo of CSHL volleyball participants playing on sand court 2001

CSHL serves up its 30th season of volleyball

8/3/2021

People have been playing volleyball at CSHL for decades. The league returned for its 30th season in the summer of 2021. Read the story »

Krainer wins Gabbay Award for SMA research

6/28/2021

CSHL Professor Adrian Krainer won the Jacob and Louise Gabbay Award in Biotechnology and Medicine for his work on spinal muscular atrophy (SMA). Read the story »

photo of Maria Luisa Pineda working in a lab

Envisagenics and Biogen partner for RNA splicing research

6/9/2021

CSHL spin-out company Envisagenics teams up with Biogen to advance research in RNA-based therapeutics for central nervous system diseases. Read the story »

Krainer wins 2021 Wolf Prize in Medicine

2/17/2021

CSHL Professor Adrian Krainer was awarded the 2021 Wolf Prize in Medicine for his work on RNA splicing. Read the story »

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.